HeartFlow Inc. announced that four Blue Cross Blue Shield companies have each issued a positive medical policy for the HeartFlow FFRct (fractional flow reserve-computed tomography) Analysis.

August 9, 2017 — Ra Medical Systems announced that the United States Patent and Trademark Office (USPTO) has granted the company a broad patent (No. 9700655) that covers its DABRA catheter for cardiovascular disease treatment. The patent was granted on July 11, 2017, and assigned to Ra Medical Systems. The inventors include Ra Medical Systems Director of Research and Development, James Laudenslager, Ph.D., and CEO/CTO Dean Irwin. DABRA (Destruction of Arteriosclerotic Blockages by laser Radiation Ablation) recently received U.S.

Roxwood Medical Inc. recently announced it has entered into an exclusive agreement with Abbott for distribution of Roxwood products in the United States.

UCSD Cardiac Lead Management Symposium

August 8, 2017 — Radical changes to our healthcare system accounting for the unique needs of women, including minority populations, are needed to ensure women receive the same high-quality care as men, according to a review paper published in the Journal of the American College of Cardiology.

AUM Cardiovascular announced it has received clearance from the U.S. Food and Drug Administration (FDA) for CADence, a non-invasive acoustic and electrocardiogram (ECG) device designed to help physicians detect physiological and pathological heart murmurs.

Virtual Phantoms Inc. announced the release of VirtualDoseIR, a tool for assessing organ dose from interventional radiology (IR) procedures. Like its VirtualDose CT product for computed tomography, VirtualDoseIR combines a family of anatomically realistic human phantoms, advanced Monte Carlo simulations, and an easy-to-use web interface to provide realistic calculations of dose to a diverse patient population.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now